ULBP1 Antikörper (AA 1-234)

Produktnummer ABIN1501673

Produktdetails anti-ULBP1 Antikörper

Target: ULBP1 (UL16 Binding Protein 1 (ULBP1))

Bindungsspezifität: AA 1-234

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ULBP1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Human ULBP1

Homologie: Percent identity by BLAST analysis:

Aufreinigung: Immunoaffinity purified

Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 234 of ULBP1 (SwissProt Q9BZM6). Percent identity by BLAST analysis:

Type of Immunogen: Recombinant protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: WB (1:500 - 1:3000)

Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal

Konservierungsmittel: Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.

Details zu ULBP1

Target: ULBP1 (UL16 Binding Protein 1 (ULBP1))

Andere Bezeichnung: ULBP1 (ULBP1 Produkte)

Synonyme: RAET1I antikoerper, A430108B07Rik antikoerper, MULT1 antikoerper, ULBP1 antikoerper, UL16 binding protein 1 antikoerper, UL16 binding protein 21 antikoerper, NKG2D ligand 1 antikoerper, ULBP1 antikoerper, ULBP21 antikoerper, Ulbp1 antikoerper, LOC100683099 antikoerper

Hintergrund: Name/Gene ID: ULBP1

Synonyms: ULBP1, Alcan-beta, N2DL1, NKG2DL1, NKG2D ligand 1, RAET1I, N2DL-1, UL16 binding protein 1, UL16-binding protein 1

Gen-ID: 80329

UniProt: Q9BZM6

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process